Literature DB >> 10094108

Characteristics of recovery from the euthyroid sick syndrome induced by tumor necrosis factor alpha in cancer patients.

R A Feelders1, A J Swaak, J A Romijn, A M Eggermont, E T Tielens, G Vreugdenhil, E Endert, H G van Eijk, A Berghout.   

Abstract

Cytokines have been implicated in the pathogenesis of the euthyroid sick syndrome. Isolated limb perfusion (ILP) with recombinant human tumor necrosis factor alpha (rTNF) and melphalan in patients with melanoma or sarcoma is accompanied by high systemic TNF levels. We examined the prolonged effects (7 days) of ILP on thyroid hormone metabolism with respect to induction and recovery of the euthyroid sick syndrome in six cancer patients. After ILP, when the limb is reconnected to the systemic circulation, leakage of residual rTNF resulted in systemic peak levels at 10 minutes postperfusion followed by a parallel increase in plasma interleukin-6 (IL-6) and cortisol, with maximum levels at 4 hours (P < .05). A rapid decrease was observed at 5 minutes for plasma triiodothyronine (T3), reverse T3 (rT3), thyroxine (T4), and thyroxine-binding globulin (TBG) (P < .05), whereas free T4 (FT4) and T3-uptake showed a sharp increase, with peak levels at 5 minutes (P < .05). T3, T4, and TBG levels remained low until 24 hours after ILP In contrast, rT3 increased above pretreatment values to maximum levels at 24 hours (P < .05). Plasma thyrotropin (TSH) showed an initial decrease at 4 hours postperfusion (P < .05) but exceeded pretreatment values from day 1 to day 7 (by +94%+/-43% to +155%+/-66%, P < .05), preceding the recovery of T4 and T3 levels. T3 and rT3 returned to initial values at day 4. T4 and TBG levels recovered at day 2. T4 exceeded basal values at days 5 to 7 (P < .05). It is concluded that ILP with rTNF induces a euthyroid sick syndrome either directly or indirectly through other mediators such as IL-6 or cortisol. The recovery from this euthyroid sick syndrome is, at least in part, TSH-dependent, since the prolonged elevation of TSH values preceded and persisted during the normalization of T3 and the elevation of T4 levels. This biphasic pattern of induction of and recovery from the euthyroid sick syndrome may be a general feature of nonthyroidal disease. The euthyroid sick syndrome should be interpreted not only in relation to the presence of nonthyroidal diseases but also in relation to the recovery from these diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094108     DOI: 10.1016/s0026-0495(99)90080-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

Review 1.  Euthyroid Sick Syndrome and the role of cytokines.

Authors:  D A Papanicolaou
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  High prevalence of non-thyroidal illness syndrome in patients at long-term care facilities.

Authors:  Joaquin Lado-Abeal; Carmen Diaz; Gilbert Berdine; Kenneth Iwuji; David Araujo-Vilar; Natalia Lampon-Fernandez; Min Wang; Santiago Lojo; Alfonso Rodriguez-Perez; Ana Marcella Rivas
Journal:  Endocrine       Date:  2020-04-28       Impact factor: 3.633

3.  Can non-thyroid illness syndrome predict mortality in lung cancer patients? A prospective cohort study.

Authors:  Zehra Asuk Yasar; Cenk Kirakli; Ufuk Yilmaz; Zeynep Zeren Ucar; Fahrettin Talay
Journal:  Horm Cancer       Date:  2014-05-16       Impact factor: 3.869

Review 4.  Abnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical Settings.

Authors:  Arnaldo Moura Neto; Denise Engelbrecht Zantut-Wittmann
Journal:  Int J Endocrinol       Date:  2016-10-10       Impact factor: 3.257

Review 5.  Nonthyroidal Illness Syndrome Across the Ages.

Authors:  Lies Langouche; An Jacobs; Greet Van den Berghe
Journal:  J Endocr Soc       Date:  2019-10-16

Review 6.  The cytokine storm and thyroid hormone changes in COVID-19.

Authors:  L Croce; D Gangemi; G Ancona; F Liboà; G Bendotti; L Minelli; L Chiovato
Journal:  J Endocrinol Invest       Date:  2021-02-09       Impact factor: 4.256

Review 7.  Thyroid Hormones Interaction With Immune Response, Inflammation and Non-thyroidal Illness Syndrome.

Authors:  Roberto De Luca; Paul J Davis; Hung-Yun Lin; Fabio Gionfra; Zulema A Percario; Elisabetta Affabris; Jens Z Pedersen; Cinzia Marchese; Pankaj Trivedi; Eleni Anastasiadou; Roberto Negro; Sandra Incerpi
Journal:  Front Cell Dev Biol       Date:  2021-01-21

8.  Sick Euthyroid Syndrome on Presentation of Patients With COVID-19: A Potential Marker for Disease Severity.

Authors:  Yair Schwarz; Ruth Percik; Bernice Oberman; Dana Yaffe; Eyal Zimlichman; Amir Tirosh
Journal:  Endocr Pract       Date:  2021-01-11       Impact factor: 3.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.